Poland· PL-100480862

Dromyc

A antiinfectives product containing clotrimazolum, registered in Poland by Laboratorios Salvat, S.A.. The same ATC class is registered in 3 of our 19 countries.

ATC S02AA

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDromycATCS02AAREGISTER NO.PL-100480862PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Clotrimazolum is registered in 3 of 19 countries.

Countries holding a registration under ATC S02AA (antiinfectives), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Clotrimazolum · ATC S02AA

3 / 19 countries

  • Denmark
  • Finlandprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Clotrimazolum
Manufacturer
Laboratorios Salvat, S.A.
Country
Poland (PL)
ATC code
S02AA
ATC class
Antiinfectives
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    08435214417948

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Clotrimazolum in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All clotrimazolum products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Candibene, Canesten
  • Belgium · Canestene Gyn, Canestene Intim
  • Bulgaria · Канестен, Канестен Гин
  • Cyprus · Canesten, Mycoril
  • Czechia · Candibene, Canesten
  • Germany · Antifungol Hexal 3 Vaginalcreme Hexal Ag, Antifungol Hexal Creme
  • Denmark · Canesten, Canvag
  • Estonia · Canesten, Canifug
  • Spain · Canesmed, Canespie
  • Finland · Canesderm, Canesten
  • France · Clotrimazole Eg Labo Conseil, Mycohydralin
  • United Kingdom (Northern Ireland) · Albican, Almus Antifungal
  • Greece · Canesten
  • Croatia · Canesten, Canesten 3
  • Hungary · Candibene, Canesten
  • Ireland · Canesten, Canesten Athlete’s Foot
  • Iceland · Canesten
  • Italy · Antimicotico Same, Candazol
  • Lithuania · Canesten, Canifug Cremolum
  • Luxembourg · Canestene Gyn, Canestene Intim
  • Latvia · Canesten, Canifug Cremolum
  • Malta · Canesten, Canesten Combi
  • Netherlands · Canesten Foot, Canesten Gyno
  • Norway · Canesten, Canesten (Kombinasjonspakning)
  • Portugal · Candigen, Candiset 3 Dias
  • Romania · Canesten, Canesten Gyn 3
  • Sweden · Canesten, Clotic
  • Slovenia · Canesten, Canesten1
  • Slovakia · Candibene, Canesten

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b07e6b14-c879-4a38-8bf5-74e4dc50d2d6
GET /v1/drugs/b07e6b14-c879-4a38-8bf5-74e4dc50d2d6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krople do uszu, roztwór w pojemniku jednodawkowym",
  "source": "urpl",
  "strength": "10 mg/ml",
  "packaging": "08435214417948 ¦ Rp ¦ 162218\n30 poj. jednodawkowych 0,2 ml",
  "substance": "Clotrimazolum 10 mg/ml",
  "common_name": "Clotrimazolum",
  "pl_product_id": "100480862",
  "pozwolenie_nr": "29233",
  "auth_procedure": "DCP",
  "authorisation_validity": "2030-08-08"
}

See everything about clotrimazolum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.